[3H]PD 128907, a Putatively Selective Ligand for the D3 Dopamine Receptor, in Rat Brain: a Receptor Binding and Quantitative Autoradiographic Study Gregory N

Total Page:16

File Type:pdf, Size:1020Kb

[3H]PD 128907, a Putatively Selective Ligand for the D3 Dopamine Receptor, in Rat Brain: a Receptor Binding and Quantitative Autoradiographic Study Gregory N Binding of [3H]PD 128907, a Putatively Selective Ligand for the D3 Dopamine Receptor, in Rat Brain: A Receptor Binding and Quantitative Autoradiographic Study Gregory N. Bancroft, B.S., Kimberly A. Morgan, B.S., Rebecca J. Flietstra, Ph.D., and Beth Levant, Ph.D. [3H]PD 128907 has been proposed as a selective ligand for on the binding of either ligand. These observations indicate the D3 dopamine receptor. This study characterizes the labeling of a dopaminergic site with characteristics binding of this radioligand in rat brain using in vitro consistent with the D3 receptor. In autoradiographic radioligand binding and autoradiographic methods. In studies, highest densities of [3H]PD 128907–labeled sites radioligand binding studies, [3H]PD 128907 exhibited 0.3 were observed in islands of Calleja followed by the nucleus nmol/L affinity for a single, low density site in ventral accumbens, nucleus of the horizontal limb of the diagonal striatal membranes. The pharmacological profile for [3H]PD band, the molecular layer of cerebellar lobule X, and the 128907 was similar to that of [3H](1)-7-OH-DPAT with ventral caudate/putamen. [Neuropsychopharmacology the rank order of potency for dopamine agonists being PD 18:305–316, 1998] © 1998 American College of 128907 ø 7-OH-DPAT ø quinpirole > dopamine; for Neuropsychopharmacology. Published by Elsevier antagonists, spiperone . (1)-butaclamol ø domperidone > Science Inc. haloperidol . SCH 23390. Guanyl nucleotides had no effect 3 3 KEY WORDS: [ H]PD 128907; [ H]7-OH-DPAT; D3 (Bouthenet et al. 1991; Sokoloff et al. 1990). These brain dopamine receptor; Rat brain; Receptor binding; Receptor regions are terminal fields of the mesolimbic dopamine autoradiography projection that is hypothesized to be involved in pro- [3H]PD 128907 has been identified as a putatively selec- ducing psychotic symptoms in schizophrenia (Stevens 1973). Furthermore, unlike mRNA for the D2 receptor, tive ligand for the D3 dopamine receptor (Akunne et al. relatively little D3 mRNA is expressed in the caudate/ 1995). A member of the D2 receptor family, the D3 site is of particular interest because its mRNA is expressed putamen (Bouthenet et al. 1991; Sokoloff et al. 1990). preferentially in brain regions such as the nucleus ac- This suggests that the D3 site may be a target for novel cumbens, olfactory tubercle, and islands of Calleja antipsychotic drugs that might be free of extrapyrami- dal effects. It has also been suggested that the D3 recep- tor may play a role in the reinforcing properties of co- From the Department of Pharmacology (BL), Toxicology, and caine (Caine and Koob 1993) and might thus represent a Therapeutics, University of Kansas Medical Center, Kansas City, Kansas. potential target in the treatment of drug abuse. Address correspondence to: Beth Levant, Ph.D., Department of Since the cloning of the D3 receptor, several radioli- Pharmacology, University of Kansas Medical Center, 3901 Rainbow gands thought to be selective for this site have been syn- Blvd., Kansas City, KS 66160-7417. 3 1 Received March 14, 1997; revised August 14, 1997; accepted thesized including [ H]PD 128907 (R-( )-trans-3,4,4a, August 18, 1997. 10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[3,4-b]- NEUROPSYCHOPHARMACOLOGY 1998–VOL. 18, NO. 4 © 1998 American College of Neuropsychopharmacology Published by Elsevier Science Inc. 0893-133X/98/$19.00 655 Avenue of the Americas, New York, NY 10010 PII S0893-133X(97)00162-0 306 G.N. Bancroft et al. NEUROPSYCHOPHARMACOLOGY 1998–VOL. 18, NO. 4 1,4-oxazin-9-ol]) (Akunne et al. 1995) and [3H]7-OH- dition of membrane homogenate. Nonspecific binding DPAT (7-hydroxy-diphenylaminotetralin) (Lévesque et al. was defined by 10 mmol/L quinpirole. Preliminary ex- 1992). However, there is some controversy over the se- periments indicated the optimal incubation time at 238C 3 lectivity of [ H]7-OH-DPAT for the D3 receptors over to be 3 h. The reaction was terminated by rapid filtration the D2 (Gonzales and Sibley 1995). Interaction of the through Whatman GF/B filters pretreated with 0.5% ligand with the sigma site has also been reported (Wal- polyethyleneimine using a Brandel cell harvester. Fil- lace and Booze 1995). Although confusion over the se- ters were washed 3 times with 3 ml ice-cold buffer (50 lectivity of [3H]7-OH-DPAT may be due to the use of mmol/L Tris; pH 7.4 at 238C), and placed in scintilla- different assay protocols, the conflicting reports have tion vials. After the addition of Beckman Ready limited the utility of this ligand as a tool for the study of Protein1 scintillation cocktail, vials were shaken, al- D3 sites in brain. On the other hand, PD 128907 pro- lowed to equilibrate for 2 h, and radioactivity quanti- duced behavioral and neurochemical effects in brain tated using a Beckman 6500 scintillation counter. Pro- suggestive of activity at the D3 site (Pugsley et al. 1995). tein concentrations were determined using the BCA Likewise, [3H]PD 128907 exhibited significant selectiv- method (Pierce, Rockford, IL). Specific binding of [3H]PD ity in transfected cell lines (Akunne et al. 1995). How- 128907 is expressed as fmol/mg protein. Data from sat- ever, the utility of this ligand in rat brain has not yet uration and competition experiments were analyzed been demonstrated. using the nonlinear least-squares curve-fitting program Because comprehensive study of a novel receptor LIGAND. Results are expressed as the mean 6 SE. system in brain requires the ability to selectively visual- ize the receptor protein, as well as receptor mRNA, the 3 1 3 [ H]( )-7-OH-DPAT Binding Assays utility of [ H]PD 128907 as a D3-selective agent was eval- uated. The pharmacological profile, guanyl nucleotide Assays were performed as described for [3H]PD 128907 regulation, and regional distribution of [3H]PD 128907– (see above) with the following exceptions. Membranes labeled sites in rat brain are described and assessed us- were prepared in assay buffer (50 mmol/L HEPES, 1 ing receptor binding and quantitative autoradiographic mmol/L EDTA; pH 7.4, at 48C) to yield a final concen- methods. tration of 7.5 mg o.w.w./ml. The concentration of [3H] (1)-7-OH-DPAT (139 Ci/mmol; Amersham, Arlington Heights, IL) was z0.2 nmol/L for single point assays. MATERIALS AND METHODS Nonspecific binding was defined by 10 mmol/L quin- pirole. Preliminary experiments indicated the optimal [3H]PD 128907 Binding Assays incubation time at 238C to be 1 h. Bound ligand was The [3H]PD 128907 binding assays were performed ac- separated from free by rapid filtration through un- cording to a modification of the methods of Akunne et treated Whatman GF/B filters. The wash buffer was 50 al. (1995). Discrete brain regions were isolated by free- mmol/L Tris, 120 mmol/L NaCl; pH 7.4 at 238C. hand dissection on ice from the brains of adult male Sprague-Dawley rats (Harlan Bioproducts, Indianapolis, Receptor Autoradiography with [3H]PD 128907 IN). Brain tissue was homogenized with a PRO250 Ho- mogenizer (setting 4 of 6) for 10 s in 20 volumes of as- Adult male Sprague-Dawley (200–300 g; Charles River say buffer (50 mmol/L Tris, 1 mmol/L EDTA; pH 7.4). Laboratories, Wilmington, DE) were killed by decapita- The crude homogenate was centrifuged twice at 48,000 3 tion, brains rapidly removed, frozen in isopentane, and g for 15 min, resuspending the pellet in 20 volumes of as- stored at 2708C until sectioning. Sagittal and coronal say buffer each time. The final pellet from membrane brain sections (20 mm) were cut on a cryostat, thaw- preparation was resuspended in buffer to yield a final mounted onto chrome-alum/gelatin-coated slides and concentration of 10 mg original wet weight (o.w.w.)/ stored at 2708C until use. ml. Binding assays were performed in duplicate in dis- [3H]PD 128907 autoradiography was performed ac- posable polystyrene tubes. The final assay volume was cording to a modification of methods previously de- 0.5 ml. For binding site saturation studies, 8–10 concen- scribed (Levant et al. 1993). Optimal assay conditions trations of (1)-[N-propyl-2,3-3H]PD 128907 (116 Ci/ were determined in preliminary wash-out and associa- mmol; Amersham, Arlington Heights, IL) were used. tion experiments. Slide-mounted brain sections were For all other studies, the final concentration of [3H]PD brought to room temperature and allowed to dry thor- 128907 was z0.3 nmol/L. Unless otherwise noted, ven- oughly. Duplicate sections from the same animal were tral striatal (nucleus accumbens and olfactory tubercle) used for each data point. Slides were incubated with membranes were incubated with [3H]PD 128907 and z0.7 nmol/L [3H]PD 128907 in assay buffer (50 mmol/ various concentrations of competing drugs (RBI, Nat- L Tris, 1 mmol/L EDTA, pH 7.4 at 238C) for 2 h at 238C. ick, MA) or 59-guanylyl-imidodiphosphate (Gpp(NH)p) Nonspecific binding was defined in the presence of 1 (Sigma, St. Louis, MO). Binding was initiated by the ad- mmol/L spiperone. After incubation, slides were dipped NEUROPSYCHOPHARMACOLOGY 1998–VOL. 18, NO. 4 [3H]PD 128907 Binding in Brain 307 in ice-cold assay buffer, washed for two consecutive and length of incubation (data not shown). When used z 2-min periods in ice-cold assay buffer, dipped in ice- at a concentration equal to the KD value ( 0.3 nmol/L), 3 cold deionized H2O, and dried under a cool air stream. [ H]PD 128907 binding reached steady state within 3 h Radiolabeled sections were subsequently apposed to at 238C. At a final tissue concentration of 10 mg o.w.w./ 3H-Hyperfilm (Amersham, Arlington Heights, IL) with ml, less than 3% of the total [3H]PD 128907 was bound 20 mm [3H]methylmethacrylate autoradiographic stan- at steady state.
Recommended publications
  • The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus Lee A
    The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus Lee A. Dawson, Ph.D., Huy Q. Nguyen, B.S., and Ping Li, B.S. Preclinical evidence has suggested a possible role for the 5-HT6 increases in extracellular glutamate levels in both frontal receptor in the treatment of cognitive dysfunction. However, cortex and dorsal hippocampus, respectively. These effects were currently there is little neurochemical evidence suggesting the completely attenuated by infusion of tetrodotoxin but mechanism(s) which may be involved. Using the selective unaffected by the muscarinic antagonist, atropine. Here we 5-HT6 antagonist SB-271046 and in vivo microdialysis, we demonstrate for the first time the selective enhancement of have evaluated the effects of this compound on the modulation excitatory neurotransmission by SB-271046 in those brain of basal neurotransmitter release within multiple brain regions regions implicated in cognitive and memory function, and of the freely moving rat. SB-271046 produced no change in provide mechanistic evidence in support of a possible basal levels of dopamine (DA), norepinephrine (NE) or 5-HT therapeutic role for 5-HT6 receptor antagonists in the in the striatum, frontal cortex, dorsal hippocampus or nucleus treatment of cognitive and memory dysfunction. accumbens. Similarly, this compound had no effect on [Neuropsychopharmacology 25:662–668, 2001] excitatory neurotransmission in the striatum or nucleus © 2001 American College of Neuropsychopharmacology. accumbens. Conversely, SB-271046 produced 3- and 2-fold Published by Elsevier Science Inc. KEY WORDS: 5-HT6 receptor; SB-271046; Microdialysis; sma et al. 1993; Ruat et al.
    [Show full text]
  • Amygdaloid Projections to the Ventral Striatum in Mice: Direct and Indirect Chemosensory Inputs to the Brain Reward System
    ORIGINAL RESEARCH ARTICLE published: 22 August 2011 NEUROANATOMY doi: 10.3389/fnana.2011.00054 Amygdaloid projections to the ventral striatum in mice: direct and indirect chemosensory inputs to the brain reward system Amparo Novejarque1†, Nicolás Gutiérrez-Castellanos2†, Enrique Lanuza2* and Fernando Martínez-García1* 1 Departament de Biologia Funcional i Antropologia Física, Facultat de Ciències Biològiques, Universitat de València, València, Spain 2 Departament de Biologia Cel•lular, Facultat de Ciències Biològiques, Universitat de València, València, Spain Edited by: Rodents constitute good models for studying the neural basis of sociosexual behavior. Agustín González, Universidad Recent findings in mice have revealed the molecular identity of the some pheromonal Complutense de Madrid, Spain molecules triggering intersexual attraction. However, the neural pathways mediating this Reviewed by: Daniel W. Wesson, Case Western basic sociosexual behavior remain elusive. Since previous work indicates that the dopamin- Reserve University, USA ergic tegmento-striatal pathway is not involved in pheromone reward, the present report James L. Goodson, Indiana explores alternative pathways linking the vomeronasal system with the tegmento-striatal University, USA system (the limbic basal ganglia) by means of tract-tracing experiments studying direct *Correspondence: and indirect projections from the chemosensory amygdala to the ventral striato-pallidum. Enrique Lanuza, Departament de Biologia Cel•lular, Facultat de Amygdaloid projections to the nucleus accumbens, olfactory tubercle, and adjoining struc- Ciències Biològiques, Universitat de tures are studied by analyzing the retrograde transport in the amygdala from dextran València, C/Dr. Moliner, 50 ES-46100 amine and fluorogold injections in the ventral striatum, as well as the anterograde labeling Burjassot, València, Spain. found in the ventral striato-pallidum after dextran amine injections in the amygdala.
    [Show full text]
  • M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Defic
    M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats Geoffrey B. Varty, Ph.D., Vaishali P. Bakshi, Ph.D., and Mark A. Geyer, Ph.D. a In a recent study using Wistar rats, the serotonergic 5-HT2 1 receptor agonist cirazoline disrupts PPI. As risperidone a receptor antagonists ketanserin and risperidone reduced the and M100907 have affinity at the 1 receptor, a final study disruptive effects of the noncompetitive N-methyl-D- examined whether M100907 would block the effects of aspartate (NMDA) antagonist dizocilpine on prepulse cirazoline on PPI. Risperidone partially, but inhibition (PPI), suggesting that there is an interaction nonsignificantly, reduced the effects of dizocilpine in Wistar between serotonin and glutamate in the modulation of PPI. rats, although this effect was smaller than previously In contrast, studies using the noncompetitive NMDA reported. Consistent with previous studies, risperidone did antagonist phencyclidine (PCP) in Sprague–Dawley rats not alter the effects of dizocilpine in Sprague–Dawley rats. found no effect with 5-HT2 antagonists. To test the hypothesis Most importantly, M100907 pretreatment fully blocked the that strain differences might explain the discrepancy in effect of dizocilpine in both strains; whereas SDZ SER 082 these findings, risperidone was tested for its ability to had no effect. M100907 had no influence on PPI by itself reduce the PPI-disruptive effects of dizocilpine in Wistar and did not reduce the effects of cirazoline on PPI. These and Sprague–Dawley rats. Furthermore, to determine studies confirm the suggestion that serotonin and glutamate which serotonergic receptor subtype may mediate this effect, interact in modulating PPI and indicate that the 5-HT2A the 5-HT2A receptor antagonist M100907 (formerly MDL receptor subtype mediates this interaction.
    [Show full text]
  • Gene Expression of Prohormone and Proprotein Convertases in the Rat CNS: a Comparative in Situ Hybridization Analysis
    The Journal of Neuroscience, March 1993. 73(3): 1258-1279 Gene Expression of Prohormone and Proprotein Convertases in the Rat CNS: A Comparative in situ Hybridization Analysis Martin K.-H. Schafer,i-a Robert Day,* William E. Cullinan,’ Michel Chri?tien,3 Nabil G. Seidah,* and Stanley J. Watson’ ‘Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48109-0720 and J. A. DeSeve Laboratory of *Biochemical and 3Molecular Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W lR7 Posttranslational processing of proproteins and prohor- The participation of neuropeptides in the modulation of a va- mones is an essential step in the formation of bioactive riety of CNS functions is well established. Many neuropeptides peptides, which is of particular importance in the nervous are synthesized as inactive precursor proteins, which undergo system. Following a long search for the enzymes responsible an enzymatic cascade of posttranslational processing and mod- for protein precursor cleavage, a family of Kexin/subtilisin- ification events during their intracellular transport before the like convertases known as PCl, PC2, and furin have recently final bioactive products are secreted and act at either pre- or been characterized in mammalian species. Their presence postsynaptic receptors. Initial endoproteolytic cleavage occurs in endocrine and neuroendocrine tissues has been dem- C-terminal to pairs of basic amino acids such as lysine-arginine onstrated. This study examines the mRNA distribution of (Docherty and Steiner, 1982) and is followed by the removal these convertases in the rat CNS and compares their ex- of the basic residues by exopeptidases. Further modifications pression with the previously characterized processing en- can occur in the form of N-terminal acetylation or C-terminal zymes carboxypeptidase E (CPE) and peptidylglycine a-am- amidation, which is essential for the bioactivity of many neu- idating monooxygenase (PAM) using in situ hybridization ropeptides.
    [Show full text]
  • Distinct Transcriptomic Cell Types and Neural Circuits of the Subiculum and Prosubiculum Along 2 the Dorsal-Ventral Axis 3 4 Song-Lin Ding1,2,*, Zizhen Yao1, Karla E
    bioRxiv preprint doi: https://doi.org/10.1101/2019.12.14.876516; this version posted December 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Distinct transcriptomic cell types and neural circuits of the subiculum and prosubiculum along 2 the dorsal-ventral axis 3 4 Song-Lin Ding1,2,*, Zizhen Yao1, Karla E. Hirokawa1, Thuc Nghi Nguyen1, Lucas T. Graybuck1, Olivia 5 Fong1, Phillip Bohn1, Kiet Ngo1, Kimberly A. Smith1, Christof Koch1, John W. Phillips1, Ed S. Lein1, 6 Julie A. Harris1, Bosiljka Tasic1, Hongkui Zeng1 7 8 1Allen Institute for Brain Science, Seattle, WA 98109, USA 9 10 2Lead Contact 11 12 *Correspondence: [email protected] (SLD) 13 14 15 Highlights 16 17 1. 27 transcriptomic cell types identified in and spatially registered to “subicular” regions. 18 2. Anatomic borders of “subicular” regions reliably determined along dorsal-ventral axis. 19 3. Distinct cell types and circuits of full-length subiculum (Sub) and prosubiculum (PS). 20 4. Brain-wide cell-type specific projections of Sub and PS revealed with specific Cre-lines. 21 22 23 In Brief 24 25 Ding et al. show that mouse subiculum and prosubiculum are two distinct regions with differential 26 transcriptomic cell types, subtypes, neural circuits and functional correlation. The former has obvious 27 topographic projections to its main targets while the latter exhibits widespread projections to many 28 subcortical regions associated with reward, emotion, stress and motivation.
    [Show full text]
  • Early-Life Experience, Epigenetics, and the Developing Brain
    Neuropsychopharmacology REVIEWS (2015) 40, 141–153 & 2015 American College of Neuropsychopharmacology. All rights reserved 0893-133X/15 REVIEW ............................................................................................................................................................... www.neuropsychopharmacologyreviews.org 141 Early-Life Experience, Epigenetics, and the Developing Brain 1 ,1 Marija Kundakovic and Frances A Champagne* 1Department of Psychology, Columbia University, New York, NY, USA Development is a dynamic process that involves interplay between genes and the environment. In mammals, the quality of the postnatal environment is shaped by parent–offspring interactions that promote growth and survival and can lead to divergent developmental trajectories with implications for later-life neurobiological and behavioral characteristics. Emerging evidence suggests that epigenetic factors (ie, DNA methylation, posttranslational histone modifications, and small non- coding RNAs) may have a critical role in these parental care effects. Although this evidence is drawn primarily from rodent studies, there is increasing support for these effects in humans. Through these molecular mechanisms, variation in risk of psychopathology may emerge, particularly as a consequence of early-life neglect and abuse. Here we will highlight evidence of dynamic epigenetic changes in the developing brain in response to variation in the quality of postnatal parent–offspring interactions. The recruitment of epigenetic pathways for the
    [Show full text]
  • Olfactory Maps, Circuits and Computations
    Available online at www.sciencedirect.com ScienceDirect Olfactory maps, circuits and computations Andrew J Giessel and Sandeep Robert Datta Sensory information in the visual, auditory and somatosensory between local positional features to extract information systems is organized topographically, with key sensory features like object identity, depth and motion [4–6]. Unlike the ordered in space across neural sheets. Despite the existence of a small number of continuous sensory parameters that spatially stereotyped map of odor identity within the olfactory characterize vision, audition and touch (such as position, bulb, it is unclear whether the higher olfactory cortex uses frequency and amplitude), olfactory parameter space is topography to organize information about smells. Here, we poorly defined and highly multidimensional [7]. For review recent work on the anatomy, microcircuitry and example, any given monomolecular odorant can be neuromodulation of two higher-order olfactory areas: the described in terms of its functional groups, molecular piriform cortex and the olfactory tubercle. The piriform is an weight, chain length, bond substitution, resonance fre- archicortical region with an extensive local associational network quency or any number of additional chemical descrip- that constructs representations of odor identity. The olfactory tors. Furthermore, olfactory space is inherently tubercle is an extension of the ventral striatum that may use discrete — not only are individual odorants structurally reward-based learning rules to encode odor valence. We argue unique but many of the molecular descriptors typically that in contrast to brain circuits for other sensory modalities, both used for individual odorants (such as functional group or the piriform and the olfactory tubercle largely discard any bond substitution) cannot be mapped continuously in topography present in the bulb and instead use distributive any scheme for chemical space.
    [Show full text]
  • Rhesus Monkey Brain Atlas Subcortical Gray Structures
    Rhesus Monkey Brain Atlas: Subcortical Gray Structures Manual Tracing for Hippocampus, Amygdala, Caudate, and Putamen Overview of Tracing Guidelines A) Tracing is done in a combination of the three orthogonal planes, as specified in the detailed methods that follow. B) Each region of interest was originally defined in the right hemisphere. The labels were then reflected onto the left hemisphere and all borders checked and adjusted manually when necessary. C) For the initial parcellation, the user used the “paint over function” of IRIS/SNAP on the T1 template of the atlas. I. Hippocampus Major Boundaries Superior boundary is the lateral ventricle/temporal horn in the majority of slices. At its most lateral extent (subiculum) the superior boundary is white matter. The inferior boundary is white matter. The anterior boundary is the lateral ventricle/temporal horn and the amygdala; the posterior boundary is lateral ventricle or white matter. The medial boundary is CSF at the center of the brain in all but the most posterior slices (where the medial boundary is white matter). The lateral boundary is white matter. The hippocampal trace includes dentate gyrus, the CA3 through CA1 regions of the hippocamopus, subiculum, parasubiculum, and presubiculum. Tracing A) Tracing is done primarily in the sagittal plane, working lateral to medial a. Locate the most lateral extent of the subiculum, which is bounded on all sides by white matter, and trace. b. As you page medially, tracing the hippocampus in each slice, the superior, anterior, and posterior boundaries of the hippocampus become the lateral ventricle/temporal horn. c. Even further medially, the anterior boundary becomes amygdala and the posterior boundary white matter.
    [Show full text]
  • Amygdala Functional Connectivity, HPA Axis Genetic Variation, and Life Stress in Children and Relations to Anxiety and Emotion Regulation
    Journal of Abnormal Psychology © 2015 American Psychological Association 2015, Vol. 124, No. 4, 817–833 0021-843X/15/$12.00 http://dx.doi.org/10.1037/abn0000094 Amygdala Functional Connectivity, HPA Axis Genetic Variation, and Life Stress in Children and Relations to Anxiety and Emotion Regulation David Pagliaccio, Joan L. Luby, Ryan Bogdan, Arpana Agrawal, Michael S. Gaffrey, Andrew C. Belden, Kelly N. Botteron, Michael P. Harms, and Deanna M. Barch Washington University in St. Louis Internalizing pathology is related to alterations in amygdala resting state functional connectivity, potentially implicating altered emotional reactivity and/or emotion regulation in the etiological pathway. Importantly, there is accumulating evidence that stress exposure and genetic vulnerability impact amygdala structure/function and risk for internalizing pathology. The present study examined whether early life stress and genetic profile scores (10 single nucleotide polymorphisms within 4 hypothalamic- pituitary-adrenal axis genes: CRHR1, NR3C2, NR3C1, and FKBP5) predicted individual differences in amygdala functional connectivity in school-age children (9- to 14-year-olds; N ϭ 120). Whole-brain regression analyses indicated that increasing genetic “risk” predicted alterations in amygdala connectivity to the caudate and postcentral gyrus. Experience of more stressful and traumatic life events predicted weakened amygdala-anterior cingulate cortex connectivity. Genetic “risk” and stress exposure interacted to predict weakened connectivity between the amygdala and the inferior and middle frontal gyri, caudate, and parahippocampal gyrus in those children with the greatest genetic and environmental risk load. Furthermore, amygdala connectivity longitudinally predicted anxiety symptoms and emotion regulation skills at a later follow-up. Amygdala connectivity mediated effects of life stress on anxiety and of genetic variants on emotion regulation.
    [Show full text]
  • Chronic Amphetamine Exposure Causes Long Term Effects on Dopamine Uptake in Cultured Cells Nafisa Ferdous
    University of North Dakota UND Scholarly Commons Theses and Dissertations Theses, Dissertations, and Senior Projects January 2016 Chronic Amphetamine Exposure Causes Long Term Effects On Dopamine Uptake In Cultured Cells Nafisa Ferdous Follow this and additional works at: https://commons.und.edu/theses Recommended Citation Ferdous, Nafisa, "Chronic Amphetamine Exposure Causes Long Term Effects On Dopamine Uptake In Cultured Cells" (2016). Theses and Dissertations. 2016. https://commons.und.edu/theses/2016 This Thesis is brought to you for free and open access by the Theses, Dissertations, and Senior Projects at UND Scholarly Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of UND Scholarly Commons. For more information, please contact [email protected]. CHRONIC AMPHETAMINE EXPOSURE CAUSES LONG TERM EFFECTS ON DOPAMINE UPTAKE IN CULTURED CELLS By Nafisa Ferdous Bachelor of Science, North South University, Bangladesh 2012 A Thesis submitted to the Graduate Faculty of the University of North Dakota in partial fulfillment of the requirements for the degree of Master of Science Grand Forks, North Dakota December 2016 ii PERMISSION Title Chronic amphetamine exposure causes long term effects on dopamine uptake in cultured cells Department Biomedical Sciences Degree Master of Science In presenting this thesis in partial fulfillment of the requirements for a graduate degree from the University of North Dakota, I agree that the library of this University shall make it freely available for inspection. I further agree that permission for extensive copying for scholarly purposes may be granted by the professor who supervised my thesis work or, in his absence, by the Chairperson of the department or the Dean of the School of Graduate Studies.
    [Show full text]
  • Mechanism of Action of Antidepressants and Mood Stabilizers
    79 MECHANISM OF ACTION OF ANTIDEPRESSANTS AND MOOD STABILIZERS ROBERT H. LENOX ALAN FRAZER Bipolar disorder (BPD), the province of mood stabilizers, the more recent understanding that antidepressants share has long been considered a recurrent disorder. For more this property in UPD have focused research on long-term than 50 years, lithium, the prototypal mood stabilizer, has events, such as alterations in gene expression and neuroplas- been known to be effective not only in acute mania but ticity, that may play a significant role in stabilizing the clini- also in the prophylaxis of recurrent episodes of mania and cal course of an illness. In our view, behavioral improvement depression. By contrast, the preponderance of past research and stabilization stem from the acute pharmacologic effects in depression has focused on the major depressive episode of antidepressants and mood stabilizers; thus, both the acute and its acute treatment. It is only relatively recently that and longer-term pharmacologic effects of both classes of investigators have begun to address the recurrent nature of drugs are emphasized in this chapter. unipolar disorder (UPD) and the prophylactic use of long- term antidepressant treatment. Thus, it is timely that we address in a single chapter the most promising research rele- vant to the pharmacodynamics of both mood stabilizers and MOOD STABILIZERS antidepressants. As we have outlined in Fig. 79.1, it is possible to charac- The term mood stabilizer within the clinical setting is com- terize both the course and treatment of bipolar and unipolar monly used to refer to a class of drugs that treat BPD.
    [Show full text]
  • Neuropsychopharmacology (2015) 40, 2853–2855 © 2015 American College of Neuropsychopharmacology
    Neuropsychopharmacology (2015) 40, 2853–2855 © 2015 American College of Neuropsychopharmacology. All rights reserved 0893-133X/15 www.neuropsychopharmacology.org Commentary Neuropsychopharmacology: Reflections on 40 Volumes Alan Frazer*,1 1 Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA Neuropsychopharmacology (2015) 40, 2853–2855; doi:10.1038/npp.2015.290 This issue completes volume 40 of Neuropsychopharmaco- methodology has not followed in concert with pre-clinical logy (NPP), with the first issue published in December, 1987. advances such that most efficacy studies still lump together This should be distinguished from our 40th anniversary; what are heterogeneous groups of patients. One might say for the first several years, issues were thin, months were how can we subdivide in the absence of biomarkers, which skipped, and multiple volumes were published per year. To do not exist? But one might also ask how can we hope to find commemorate this accomplishment, the editor-in-chief a biomarker among a group of patients that might have 3, 7, (Dr Carlezon) asked me as in-coming ACNP President to or 10 different pathologies, all leading to the same behavioral write a brief overview of my views on the developments in output. Talk about the chicken and the egg! our field over this time period, using highly cited articles Another theme that continues into the present is the time- published in NPP as a guide. dependent, downstream consequences of acute actions of Early on, two articles highlight themes that continue today. some type of psychotherapeutic drugs that correlate better One is the development of animal models for psychiatric with optimal clinical improvement.
    [Show full text]